e-learning
resources
ERJ
2013
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Simvastatin-induced effects on bronchial epithelial cells from COPD donors
Lena Uller
Source:
Eur Respir J 2013; 41: 1464-1465
Journal Issue:
June
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Lena Uller. Simvastatin-induced effects on bronchial epithelial cells from COPD donors. Eur Respir J 2013; 41: 1464-1465
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
Simvastatin selectively inhibits TSLP-production in primary bronchial epithelial cells from COPD donors
Source: Annual Congress 2011 - Translational models of disease
Year: 2011
Disease specific effects of adrenomedullin in COPD and asthma derived human bronchial epithelial cells
Source: International Congress 2015 – Immunomodulation: basic science and clinical aspects
Year: 2015
Characterization of well-differentiated bronchial epithelial cells derived from severe COPD patients
Source: Virtual Congress 2021 – Advanced in vitro models for drug discovery
Year: 2021
Interaction between epithelial cells and sub-epithelial mesenchymal cells in severe non-allergic asthma
Source: International Congress 2019 – Pathophysiology and clinical insights into severe non-allergic asthma
Year: 2019
Bronchial mucosal dendritic cells and VEGF expression in COPD patients
Source: Annual Congress 2012 - Airway diseases: from invasive to noninvasive biomarkers
Year: 2012
Senescent human bronchial epithelial cells induce small airway fibrosis in mice
Source: Virtual Congress 2021 – Emerging new mechanisms of chronic lung disease
Year: 2021
Investigating the effects of interleukin-33 on rhinovirus A induced changes in asthmatic bronchial epithelial cells
Source: Virtual Congress 2020 – Novel molecular markers and targets for asthma phenotypes
Year: 2020
Mucine secretion by airways epithelial cells in chronic obstructive lung disease
Source: Annual Congress 2004 - Epithelial - microenvironmental interactions in neoplastic and non-neoplastic lung diseases
Year: 2004
cKIT cells in human bronchial epithelium in asthma
Source: International Congress 2018 – A fresh view on airway differentiation and regeneration
Year: 2018
Upregulation of GABAergic system in human bronchial epithelial cells in severe asthma
Source: Annual Congress 2009 - Translational models of lung disease
Year: 2009
Investigation of the CFTR-TGFß1 interaction in inflammatory and fibrotic processes in healthy and CFTR-mutated human bronchial epithelial cells
Source: International Congress 2019 – Infection and inflammation in cystic fibrosis
Year: 2019
CCSP modulates inflammation in bronchial epithelium differentiated
ex vivo
from bronchial biopsy of COPD patients
Source: Annual Congress 2010 - Novel cellular mechanisms in lung disease
Year: 2010
How cultured epithelial cells from asthma and COPD patients deal with pathogens: defective anti-rhinovirus responses in asthma
Source: Research Seminar 2008 - Host-pathogen interactions in the lung: implications for treatment of respiratory infections and inflammatory lung diseases
Year: 2008
The expression of TSLP in monocyte derived dendritic cells in the interactions between respiratory epithelium and macrophages in asthma, COPD and healthy controls
Source: International Congress 2019 – Novel insights from in vitro and in vivo models of lung disease
Year: 2019
Altered phenotype of COPD primary fibroblasts from airway and alveolar tissues: proliferation and apoptosis.
Source: International Congress 2019 – Research and innovation in airway diseases
Year: 2019
Increased numbers of alveolar mast cells with an altered phenotype are linked to peripheral airway remodelling in patients with allergic asthma
Source: Annual Congress 2012 - Mechanisms of asthma
Year: 2012
Capsazepine inhibits NF-κB subunits in dsRNA-exposed human bronchial epithelial cells from asthmatic and COPD donors
Source: Annual Congress 2011 - Translational models of airway disease
Year: 2011
Effects of chronic exposure to IL-13 on mucociliary differentiation of epithelial cells obtained from asthmatic and non-asthmatic children
Source: Annual Congress 2009 - COPD and asthma - from the cell to the clinic
Year: 2009
Upregulation of MCAM in primary bronchial epithelial cells from patients with COPD
Source: Eur Respir J 2003; 22: 450-456
Year: 2003
Chemokine release in response to
Streptococcus pneumoniae
, by primary bronchial epithelial cells of patients with severe asthma and healthy controls
Source: Annual Congress 2009 - Novel mechanisms in the pathogenesis of asthma
Year: 2009
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept